Quarterly Report · 10-Q
Oramed Pharmaceuticals Inc.
ORMPNASDAQEQUITYCurrent
Quarterly Report
Company context
Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) is a clinical-stage pharmaceutical company and platform technology pioneer in oral delivery solutions for drugs currently delivered via injection. Oramed’s Protein Oral Delivery (POD™) technology is designed to protect drug integrity and increase absorption. Oramed is building a diversified active investment portfolio while advancing its refined oral insulin program.
Current securities
As-filed source
As filedOpen full document ↗